Annual report pursuant to Section 13 and 15(d)

Schedule of Deferred Tax Assets and Liabilities (Details)

v3.24.1
Schedule of Deferred Tax Assets and Liabilities (Details) - USD ($)
$ in Thousands
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Income Tax Disclosure [Abstract]      
Share-based Compensation $ 5,383 $ 4,512  
Depreciation and Amortization (23) (18)  
Accrued Liability 307 481  
Net Operating Loss Carry-forwards 25,146 21,755  
R&D Credit Carryforwards 4,432 3,773  
R&D Section 174 Costs 5,953 4,268  
Other 1 (1)  
IPR&D (851) (851)  
ROU Asset (870) (1,027)  
ROU Liability 996 1,155  
Total Deferred tax assets 40,474 34,047  
Valuation allowance (40,815) (34,388) $ (31,023)
Net deferred tax asset (liability) $ (341) $ (341)